You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Short Cases in Pulmonary Arterial Hypertension

  • Authors: Sonja D. Bartolome, MD; Sean P. Gaine, MD, PhD, FRCPI; Brandon Jakubowski, MD; Stephan Rosenkranz, MD; Göran Rådegran, MD, MScEngPys, DMSc
  • CME Released: 8/31/2022
  • Valid for credit through: 8/31/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US cardiologists, pulmonologists, and rheumatologists.

The goal of this activity is that learners will be better able to exemplify how experts approach challenging diagnostic and treatment situations in PAH.

Upon completion of this activity, participants will:

  • Have greater competence related to
    • Selecting a treatment approach for patients with PAH presenting with severe symptoms
    • Differentially diagnosing PAH from other confounding diagnoses
    • Screening family members following a heritable PAH diagnosis
    • Selecting an escalation approach for patients who have not responded to PAH therapy
  • Demonstrate greater confidence in their ability to
    • Appropriately address challenging situations in patients with possible or diagnosed PAH


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

-


Faculty

  • Sonja D. Bartolome, MD

    Professor, Internal Medicine - Pulmonary and Critical Care Medicine 
    Medical Director of the Chronic Thromboembolic Pulmonary Hypertension Program
    Associate Director, Pulmonary Hypertension Program
    UT Southwestern Medical Center
    Dallas, Texas, United States

    Disclosures

    Sonja D. Bartolome, MD, has the following relevant financial relationships:
    Consultant or advisor for: Janssen; United Therapeutics
    Research funding from: Acceleron; Gossamer; Lung Biotechnology; Merck; PhaseBio; United Therapeutics

  • Sean P. Gaine, MD, PhD, FRCPI

    Professor
    Mater Misericordiae University Hospital
    University College Dublin
    Dublin, Ireland

    Disclosures

    Sean P. Gaine, MD, PhD, FRCPI, has the following relevant financial relationships:
    Speaker or member of speakers bureau for: Actelion; Bayer; Janssen
    Research funding from: Janssen
    Other: Independent contractor for: Acceleron; Actelion; Bayer; Janssen; United Therapeutics

  • Brandon Jakubowski, MD

    UT Southwestern Medical Center
    Dallas, Texas, United States

    Disclosures

    Brandon Jakubowski, MD, has no relevant financial relationships.

  • Göran Rådegran, MD, MScEngPys, DMSc

    Associate Professor
    Lund University
    Head, Swedish Association of Pulmonary Hypertension
    Lund, Sweden

    Disclosures

    Göran Rådegran, MD, MScEngPys, DMSc, has the following relevant financial relationships:
    Consultant or advisor for: Janssen
    Speaker or member of speakers bureau for: Janssen
    Research funding from: Infucare; Janssen; Nordic

  • Stephan Rosenkranz, MD

    Department of Cardiology
    Head of the Pulmonary Hypertension Center, University of Cologne, Germany
    Center for Molecular Medicine, Cologne (CMMC)
    Cologne Cardiovascular Research Center (CCRC)
    Heart Center at the University of Cologne
    Cologne, Germany

    Disclosures

    Stephan Rosenkranz, MD, has the following relevant financial relationships:
    Consultant or advisor for: Actelion; AstraZeneca; Bayer; Janssen; Merck Sharp & Dohme, Corp.
    Speaker or member of speakers bureau for: Actelion; AstraZeneca; Bayer; Boehringer Ingelheim; Janssen; Merck Sharp & Dohme, Corp.; Vifor
    Research funding from: Actelion; AstraZeneca; Bayer; Janssen

Editors

  • George Boutsalis, PhD

    Senior Medical Education Director, Medscape, LLC 

    Disclosures

    George Boutsalis, PhD, has no relevant financial relationships. 

  • Cheryl Perkins, MD, RPh

    Medical Education Director, Medscape, LLC 

    Disclosures

    Cheryl Perkins, MD, RPh, has no relevant financial relationships. 

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Amanda Jett, PharmD, BCACP, has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Short Cases in Pulmonary Arterial Hypertension

Authors: Sonja D. Bartolome, MD; Sean P. Gaine, MD, PhD, FRCPI; Brandon Jakubowski, MD; Stephan Rosenkranz, MD; Göran Rådegran, MD, MScEngPys, DMScFaculty and Disclosures

CME Released: 8/31/2022

Valid for credit through: 8/31/2023

processing....